The frequency and pattern of mutations at codon 61 of the c-Ha-ras gene have been analyzed in 195 liver tumors and 132 precancerous liver lesions from various rodent strains with differing susceptibility to hepatocarcinogenesis. By using the polymerase chain reaction and allele-specific oligonucleotide hybridization, C → A transversions at the first base and A → T transversions or A → G transitions at the second base of c-Ha-ras codon 61 were detected in 20-60% of spontaneous or carcinogen-induced liver tumors of the C3H/He, CBA, CF1, and B6C3F1 mouse strains, which are highly susceptible to hepatocarcinogenesis. No such mutations, however, could be found in any of the 31 liver tumors of the insensitive C57BL/6J and BALB/c mo...
Mutation in one of three RAS genes (i.e., HRAS, KRAS, and NRAS) leading to constitutive activation o...
Codon 12 of the ras protooncogenes represents a mutational hotspot in human cancer. A distinct patte...
Vertebrate genomes contain proto-oncogenes whose enhanced expression or alteration by mutation seems...
2To whom all correspondence should be addressed Previous reports from several laboratories have cons...
Spontaneous proliferative liver lesions were found in 15 (13 males and 2 females) of 244 (122 of eac...
2To whom correspondence should be addressed Mutations in codon 61 of the Ha-ras proto-oncogene have ...
Liver tumors from B6C3F1 mice induced by the potent peroxisome proliferator ciprofibrate, a hypolipi...
We investigated the role of dosing regimen on ras mutations in chemically induced CD-I mouse liver t...
14 p.A region of mouse Chromosome 1, called the Hcs7 locus, is involved in the susceptibility to liv...
In this review, genetic changes known to occur in human and experimental animal hepatocarcinogenesis...
These experiments were conducted to determine whether point mutations activating K-ras or H-ras onco...
(anfi-B[c]PhDE) is a powerful rat mammary carcinogen and is one of the most potent diol-epoxide tumo...
With the development of high-throughput genomic analysis, sequencing a mouse primary cancer model pr...
Activated ras oncogenes have been detected in a variety of human malignancies. Activation of ras onc...
are the most frequently observed K-ras point mutations in human and rodent tumors and therefore are ...
Mutation in one of three RAS genes (i.e., HRAS, KRAS, and NRAS) leading to constitutive activation o...
Codon 12 of the ras protooncogenes represents a mutational hotspot in human cancer. A distinct patte...
Vertebrate genomes contain proto-oncogenes whose enhanced expression or alteration by mutation seems...
2To whom all correspondence should be addressed Previous reports from several laboratories have cons...
Spontaneous proliferative liver lesions were found in 15 (13 males and 2 females) of 244 (122 of eac...
2To whom correspondence should be addressed Mutations in codon 61 of the Ha-ras proto-oncogene have ...
Liver tumors from B6C3F1 mice induced by the potent peroxisome proliferator ciprofibrate, a hypolipi...
We investigated the role of dosing regimen on ras mutations in chemically induced CD-I mouse liver t...
14 p.A region of mouse Chromosome 1, called the Hcs7 locus, is involved in the susceptibility to liv...
In this review, genetic changes known to occur in human and experimental animal hepatocarcinogenesis...
These experiments were conducted to determine whether point mutations activating K-ras or H-ras onco...
(anfi-B[c]PhDE) is a powerful rat mammary carcinogen and is one of the most potent diol-epoxide tumo...
With the development of high-throughput genomic analysis, sequencing a mouse primary cancer model pr...
Activated ras oncogenes have been detected in a variety of human malignancies. Activation of ras onc...
are the most frequently observed K-ras point mutations in human and rodent tumors and therefore are ...
Mutation in one of three RAS genes (i.e., HRAS, KRAS, and NRAS) leading to constitutive activation o...
Codon 12 of the ras protooncogenes represents a mutational hotspot in human cancer. A distinct patte...
Vertebrate genomes contain proto-oncogenes whose enhanced expression or alteration by mutation seems...